Hints and tips:
Enterprise tech company moves to bulk up networking offering in sign of momentum for dealmaking
...But Johnson’s point was not to get bogged down in the detail, but to embrace the big picture offer to investors....
...The planned sale would unwind the 2017 acquisition of Mead Johnson, one of its largest ever, which was made under former chief executive Rakesh Kapoor....
...The FTC’s treatment of the deal had sharpened corporate America’s concerns that Khan is ushering in a more interventionist antitrust policy....
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
...Additional reporting by Richard Waters and Andrew Edgecliffe-Johnson...
...Johnson & Johnson has agreed to buy cardiovascular technology group Abiomed for $16.6bn, including debt, a sign that mega dealmaking remains robust in the US despite geopolitical and economic uncertainty...
...Horizon said last month that it was in takeover talks with three potential suitors, among them Johnson & Johnson and Sanofi....
...& Johnson....
...Horizon’s assets, which include treatments for chronic gout and neuromyelitis optica, a disease affecting the central nervous system, had also attracted interest from Johnson & Johnson and Sanofi....
...Lina Khan, the commission’s Biden-appointed chair, has zealously attacked Big Tech mergers and acquisitions....
...“As our complaints note, Epic used privacy-invasive default settings and deceptive interfaces that tricked Fortnite users, including teenagers and children,” said FTC chair Lina Khan....
...The prices of energy, petrol and petroleum-based agricultural inputs shot up earlier this year when western nations imposed sanctions on Russia after the invasion....
...The FT’s Andrew Edgecliffe-Johnson examines whether the mega-retailer’s ESG pledges can jive with its profits-at-all-costs model....
...The PGA Tour has suspended members who have joined LIV, including stars Phil Mickelson and Dustin Johnson....
...But it has not made an offer and could decide to target Johnson & Johnson’s consumer healthcare assets, which the US company decided to spin-off in November....
...A version of this article was first published by Nikkei Asia on July 19. ©2022 Nikkei Inc. All rights reserved....
...Additional reporting by James Fontanella-Khan in New York and Sara Germano in Beijing...
...One thing to start: Boris Johnson has joined a final push to convince chip designer Arm to list in London, as UK government officials grow concerned over the lasting damage if Britain’s best-known tech company...
...DS Smith has appointed former Unilever chief financial officer Alan Johnson to its board as a non-executive director....
...Go deeper Soaring energy prices are reviving the US shale oil industry and yesterday Whiting Petroleum and Oasis Petroleum, two US shale oil producers, agreed a $6bn merger....
...Brands including Johnson & Johnson and Procter & Gamble signed up to support one event in 2019, for example, at which fans could see Usher or Janelle Monáe for free if they signed petitions, called politicians...
...The 54-year-old has been quietly plotting a comeback by launching a new Manhattan-based advisory business called Consello, DD’s James Fontanella-Khan and Arash Massoudi and the FT’s Andrew Edgecliffe-Johnson...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...mehreen.khan@ft.com; @MehreenKhndavid.hindley@ft.com...
International Edition